International Symposium on Inflammatory Bowel Diseases
Kluwer Academic Publishers (Verlag)
978-0-7923-8743-5 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
This book, the proceedings of the Fifth International Symposium on Inflammatory Bowel Diseases (Falk Symposium 101) held in Tel-Aviv, Israel, on September 22-24, 1997, is devoted to recent progress in diagnosing and treating inflammatory bowel diseases. The achievements of the years from 1948 to 1998, medical, surgical and in the basic sciences, are summarized in detail. Controversies with respect of the aetio-pathogenesis of inflammatory bowel diseases are discussed together, with pending clinical controversies, such as the best way to monitor treatment, early versus late surgery, and post-operative maintenance and surveillance. A special section is devoted to an analysis of which of the available drugs is the drug of choice. Finally, a large section deals with surgical controversies, such as laparoscopic surgery in inflammatory bowel diseases, one- versus two-stage ileo-anal anastomosis and treatment of fistula in Crohn's disease. The last section outlines needs, both in the medical sciences and in the clinic.
Section I: What was Achieved in the Last 50 Years? 1. Inflammatory Bowel Disease: Medical Achievements 1947-1997; J.E. Lennard-Jones. 2. The Surgery of Inflammatory Bowel Disease: What Have we Achieved? A.H. Aufses, Jr. 3. What Has Science Provided Over the Last 50 Years?, H.J.F. Hodgson. Section II: Aetio-Pathogenic Controversies. 4. Microbial Stimuli in IBD: Specific Agent Versus Host Response; R.B. Sartor. 5. Autoantibodies and Cytokines in IBD: First Mediators or Secondary Markers? C. Fiocchi. 6. Etio-Pathogenic Controversies. Genetics of Crohn's Disease and Ulcerative Colitis; A.S. Pena, et al. 7. What Can We Learn From Animal Models? C.O. Elson, et al. Section III: Clinical Controversies. 8. What is the Best Way to Monitor Treatment of Chronic Inflammatory Bowel Diseases? H. Goebell. 9. What is the Best Way to Monitor Treatment in IBD? Endoscopic Evaluation; R. Modigliani. 10. Earlier Surgery for Inflammatory Bowel Disease - Acute Ulcerative Colitis; Z. Cohen. 11. Clinical Controversies - Early Versus Late Surgery in Crohn's Disease and Ulcerative Colitis; D.H. Present. 12. Surveillance in Ulcerative Colitis - The Case For; R.H. Riddell. 13. The Failure of Dysplasiz Surveillance Colonoscopy in Ulcerative Colitis as a Screening Tool; C.N. Bernstein. 14. Clinical Controversies - The Case Against Routine Post-Operative Therapy for Prevention of Recurrence in Crohn's Disease; N.P. Breslin, L.R. Sutherland. 15. Smoking and IBD; T. Gilat, et al. Section IV: Medical Treatment of Inflammatory Bowel Disease. 16. The Role of Salicylate in Patients with Inflammatory Bowel Disease; M. Campieri, et al. 17. Steroids in IBD: Which Steroid for What Patient? J. Scholmerich, T. Andus. 18. For Whom is 6-MP/Imuran the Drug of Choice? D.H. Present. 19. Who Should Get Cyclosporin? D.P. Jewell, G.M. Hyde. 20. The Role of Antibiotics in the Treatment of Crohn's Disease; P. Rutgeerts. 21. Cytokine-Based Intervention Strategies in Crohn's Disease; S.J.H. van Deventer, et al. Section V: Surgery. 22. Laporoscopic Surgery for Crohn's Disease; B. Salky. 23. Laporoscopic Colorectal Surgery: The Case Against; M.G.W. Kettlewell. 24. Mayo Experience with Two-Stage Proctocolectomy and Ileal Pouch-Anal Anastomosis; J.H. Pemberton. 25. Medical Treatment of Fistulae in Crohn's Disease; D.B. Sachar. 26. Surgical Treatment of Fistulae in Crohn's Disease; J.H. Pemberton. Section VI: What Are the Needs? 27. Basic IBD Research: What Are the Needs? D.K. Podolsky. 28. Therapeutic Predictions-Emerging Drug Treatments; S.B. Hannauer. 29. New Drugs and Strategies; D. Rachmilewitz.
Erscheint lt. Verlag | 1.7.1998 |
---|---|
Reihe/Serie | Falk Symposium ; v. 101 |
Zusatzinfo | index |
Sprache | englisch |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie |
ISBN-10 | 0-7923-8743-0 / 0792387430 |
ISBN-13 | 978-0-7923-8743-5 / 9780792387435 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich